Adverse Ocular Events following COVID-19 Vaccination Taher K. EleiwaEric D. GaierAbdelrahman M. Elhusseiny Commentary 24 September 2021 Pages: 1005 - 1009
The impact of CD4+CD28null T lymphocytes on atrial fibrillation: a potential pathophysiological pathway Andreas HammerAlexander NiessnerPatrick Sulzgruber Commentary Open access 18 September 2021 Pages: 1011 - 1014
Chronic inflammation and long-lasting changes in the gastric mucosa after Helicobacter pylori infection involved in gastric cancer Hang YangBin WeiBing Hu Review 21 September 2021 Pages: 1015 - 1026
Emerging perspectives on mitochondrial dysfunctioning and inflammation in epileptogenesis Shareen SinghThakur Gurjeet Singh Review 15 October 2021 Pages: 1027 - 1042
Insulin/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: impact on the aging process and age-related diseases Antero SalminenKai KaarnirantaAnu Kauppinen Review Open access 02 September 2021 Pages: 1043 - 1061
The role of NK cells in rheumatoid arthritis Anwar FathollahiLeila Nejatbakhsh SamimiElham Farhadi Review 27 September 2021 Pages: 1063 - 1073
Association of interleukin 6 -174 G/C polymorphism with coronary artery disease and circulating IL-6 levels: a systematic review and meta-analysis Himanshu RaiRoisin ColleranRobert A. Byrne Review Open access 30 September 2021 Pages: 1075 - 1087
miR-451-3p alleviates myocardial ischemia/reperfusion injury by inhibiting MAP1LC3B-mediated autophagy Xiang-Wei LvZi-Feng HeTong-Tong Xu Original Research Article 11 October 2021 Pages: 1089 - 1100
Anti-high mobility group box 1 monoclonal antibody suppressed hyper-permeability and cytokine production in human pulmonary endothelial cells infected with influenza A virus Takahiro NambaMitsuru TsugeHirokazu Tsukahara Original Research Paper 29 August 2021 Pages: 1101 - 1111
NORAD lentivirus shRNA mitigates fibrosis and inflammatory responses in diabetic cardiomyopathy via the ceRNA network of NORAD/miR-125a-3p/Fyn Ye LiuYikun ZhuXing Li Original Research Paper 30 September 2021 Pages: 1113 - 1127
Osteoarthritic infrapatellar fat pad aggravates cartilage degradation via activation of p38MAPK and ERK1/2 pathways Zuoqing ZhouSu’an TangChanghai Ding Original Research Paper 25 September 2021 Pages: 1129 - 1139
S14G-humanin (HNG) protects retinal endothelial cells from UV-B-induced NLRP3 inflammation activation through inhibiting Egr-1 Dejing ShiXuemei ZhouHongxia Wang Original Research Paper 30 August 2021 Pages: 1141 - 1150
Gisenoside Rg1 attenuates cadmium-induced neurotoxicity in vitro and in vivo by attenuating oxidative stress and inflammation Teng-Teng RenJia-Ying YangXiao-Yan Qin Original Research Article 18 October 2021 Pages: 1151 - 1164
COVID-19 disrupts the blood–testis barrier through the induction of inflammatory cytokines and disruption of junctional proteins Tahmineh PeirouviAbbas AliaghaeiMohammad-Amin Abdollahifar Original Research Paper 26 August 2021 Pages: 1165 - 1175
Significance of glutathione peroxidase 4 and intracellular iron level in ovarian cancer cells—“utilization” of ferroptosis mechanism Dingxi LiMengli ZhangHongtu Chao Original Research Paper 19 September 2021 Pages: 1177 - 1189
C/EBPβ is a key transcription factor of ox-LDL inducing THP-1 cells to release multiple pro-inflammatory cytokines Jun MaXiangyu YangXiaoping Chen Original Research Article 04 October 2021 Pages: 1191 - 1199
Association between IL-17A, IL-17F and IL-17RA gene polymorphisms and susceptibility to psoriasis and psoriatic arthritis: a meta-analysis Fridha Viridiana Villalpando-VargasJuan José Rivera-ValdésOmar Graciano-Machuca Original Research Article 27 October 2021 Pages: 1201 - 1210
Analysis of five cases of monogenic lupus related to primary immunodeficiency diseases Gaixiu SuJianming LaiZhixuan Zhou Original Research Paper 24 September 2021 Pages: 1211 - 1216
gga-miR-142-3p negatively regulates Mycoplasma gallisepticum (HS strain)-induced inflammatory cytokine production via the NF-κB and MAPK signaling by targeting TAB2 Yaping YangYingjie WangXiuli Peng Original Research Paper 23 September 2021 Pages: 1217 - 1231
The efficacy and safety of levilimab in severely ill COVID-19 patients not requiring mechanical ventilation: results of a multicenter randomized double-blind placebo-controlled phase III CORONA clinical study Nikita V. LomakinBulat A. BakirovAnton A. Lutckii Original Research Article Open access 29 September 2021 Pages: 1233 - 1246